{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:49:16Z","timestamp":1740163756594,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH Medical Research Scholars Program"},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI001123","AI001123"],"award-info":[{"award-number":["AI001123","AI001123"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Intramural Research Program, National Institutes of Health, Bethesda, MD"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["UO1 AI109657"],"award-info":[{"award-number":["UO1 AI109657"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The morbidity and mortality of cryptococcal meningoencephalitis (CM) in previously healthy, HIV-negative individuals is increasingly recognized. We administered a healthcare associated quality of life (QOL) survey to the largest longitudinally followed cohort of these patients in the United States. We identified moderate or severe self-reported impairment in at least one QOL domain in 61% of subjects at least one year following diagnosis. Self-reported cognitive impairment was noted in 52% and sleep disturbance was noted in 55%. This is the first comprehensive study of cross-sectional long-term QOL in previously healthy patients following cryptococcal infection.<\/jats:p>","DOI":"10.1038\/s41598-021-83176-2","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T11:03:58Z","timestamp":1613041438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quality of life of HIV-negative, previously healthy individuals following cryptococcal meningoencephalitis"],"prefix":"10.1038","volume":"11","author":[{"given":"Owen","family":"Dean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seher","family":"Anjum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian","family":"Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Traino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Hunsberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"John H.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieren A.","family":"Marr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Snow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"83176_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","volume":"13","author":"PR Williamson","year":"2017","unstructured":"Williamson, P. R. et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat. Rev. Neurol. 13, 13\u201324. https:\/\/doi.org\/10.1038\/nrneurol.2016.167 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"83176_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/cid\/cix870","volume":"66","author":"E Pasquier","year":"2018","unstructured":"Pasquier, E. et al. Long-term mortality and disability in cryptococcal meningitis: a systematic literature review. Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am. 66, 1122\u20131132. https:\/\/doi.org\/10.1093\/cid\/cix870 (2018).","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"83176_CR3","doi-asserted-by":"publisher","first-page":"e60431","DOI":"10.1371\/journal.pone.0060431","volume":"8","author":"KD Brizendine","year":"2013","unstructured":"Brizendine, K. D., Baddley, J. W. & Pappas, P. G. Predictors of mortality and differences in clinical features among patients with cryptococcosis according to immune status. PLoS ONE 8, e60431. https:\/\/doi.org\/10.1371\/journal.pone.0060431 (2013).","journal-title":"PLoS ONE"},{"key":"83176_CR4","doi-asserted-by":"publisher","first-page":"18442","DOI":"10.1038\/s41598-019-54876-7","volume":"9","author":"K Traino","year":"2019","unstructured":"Traino, K. et al. HIV-negative cryptococcal meningoencephalitis results in a persistent frontal-subcortical syndrome. Sci. Rep. 9, 18442. https:\/\/doi.org\/10.1038\/s41598-019-54876-7 (2019).","journal-title":"Sci. Rep."},{"key":"83176_CR5","doi-asserted-by":"publisher","first-page":"e657","DOI":"10.1097\/MAO.0000000000002242","volume":"40","author":"KA King","year":"2019","unstructured":"King, K. A. et al. Audiologic and otologic complications of cryptococcal meningoencephalitis in non-HIV previously healthy patients. Otol. Neurotol. 40, e657\u2013e664. https:\/\/doi.org\/10.1097\/MAO.0000000000002242 (2019).","journal-title":"Otol. Neurotol."},{"key":"83176_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/cid\/ciw739","volume":"64","author":"AA Panackal","year":"2017","unstructured":"Panackal, A. A. et al. Spinal arachnoiditis as a complication of cryptococcal meningoencephalitis in non-HIV previously healthy adults. Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am. 64, 275\u2013283. https:\/\/doi.org\/10.1093\/cid\/ciw739 (2017).","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"83176_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01415-17","author":"LM Neal","year":"2017","unstructured":"Neal, L. M. et al. CD4(+) T cells orchestrate lethal immune pathology despite fungal clearance during cryptococcus neoformans meningoencephalitis. MBio https:\/\/doi.org\/10.1128\/mBio.01415-17 (2017).","journal-title":"MBio"},{"key":"83176_CR8","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1212\/WNL.0b013e318258f744","volume":"78","author":"D Cella","year":"2012","unstructured":"Cella, D. et al. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology 78, 1860\u20131867. https:\/\/doi.org\/10.1212\/WNL.0b013e318258f744 (2012).","journal-title":"Neurology"},{"key":"83176_CR9","unstructured":"9Neuro-QoL Technical Report: Development and Initial Validation of Patient-Reported Item Banks for use in Neurological Research and Practice (2015)."},{"key":"83176_CR10","first-page":"8","volume":"21","author":"CH Chen","year":"2012","unstructured":"Chen, C. H. et al. Neuro-psychological sequelae in HIV-negative cryptococcal meningitis after complete anti-fungal treatment. Acta Neurol. Taiwan 21, 8\u201317 (2012).","journal-title":"Acta Neurol. Taiwan"},{"key":"83176_CR11","doi-asserted-by":"publisher","first-page":"356476","DOI":"10.1155\/2015\/356476","volume":"2015","author":"MH Chen","year":"2015","unstructured":"Chen, M. H. et al. Long-term neuropsychological sequelae in HIV-seronegative cryptococcal meningoencephalitis patients with and without ventriculoperitoneal shunts: a cine MRI study. Behav. Neurol. 2015, 356476. https:\/\/doi.org\/10.1155\/2015\/356476 (2015).","journal-title":"Behav. Neurol."},{"key":"83176_CR12","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3174\/ajnr.A2489","volume":"32","author":"CH Lu","year":"2011","unstructured":"Lu, C. H. et al. Assessing the chronic neuropsychologic sequelae of human immunodeficiency virus-negative cryptococcal meningitis by using diffusion tensor imaging. AJNR Am. J. Neuroradiol. 32, 1333\u20131339. https:\/\/doi.org\/10.3174\/ajnr.A2489 (2011).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"83176_CR13","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1093\/geront\/gnw091","volume":"56","author":"NL Hill","year":"2016","unstructured":"Hill, N. L. et al. Subjective cognitive impairment and affective symptoms: a systematic review. Gerontologist 56, e109\u2013e127. https:\/\/doi.org\/10.1093\/geront\/gnw091 (2016).","journal-title":"Gerontologist"},{"key":"83176_CR14","doi-asserted-by":"publisher","DOI":"10.16966\/2380-5536.146","author":"M Yoo-Jeong","year":"2018","unstructured":"Yoo-Jeong, M. et al. Associations of mood on objective and subjective cognitive complaints in persons living with HIV\/AIDS. J. HIV AIDS https:\/\/doi.org\/10.16966\/2380-5536.146 (2018).","journal-title":"J. HIV AIDS"},{"key":"83176_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.clineuro.2017.10.007","volume":"163","author":"A Pranckeviciene","year":"2017","unstructured":"Pranckeviciene, A., Deltuva, V. P., Tamasauskas, A. & Bunevicius, A. Association between psychological distress, subjective cognitive complaints and objective neuropsychological functioning in brain tumor patients. Clin. Neurol. Neurosurg. 163, 18\u201323. https:\/\/doi.org\/10.1016\/j.clineuro.2017.10.007 (2017).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"83176_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s11065-016-9332-2","volume":"26","author":"B Burmester","year":"2016","unstructured":"Burmester, B., Leathem, J. & Merrick, P. Subjective cognitive complaints and objective cognitive function in aging: a systematic review and meta-analysis of recent cross-sectional findings. Neuropsychol. Rev. 26, 376\u2013393. https:\/\/doi.org\/10.1007\/s11065-016-9332-2 (2016).","journal-title":"Neuropsychol. Rev."},{"key":"83176_CR17","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/jnnp.2005.071142","volume":"77","author":"H Schmidt","year":"2006","unstructured":"Schmidt, H. et al. Sleep disorders are long-term sequelae of both bacterial and viral meningitis. J. Neurol. Neurosurg. Psychiatry 77, 554\u2013558. https:\/\/doi.org\/10.1136\/jnnp.2005.071142 (2006).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"83176_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jns.2008.01.003","volume":"269","author":"V Pardasani","year":"2008","unstructured":"Pardasani, V., Shukla, G., Singh, S., Goyal, V. & Behari, M. Abnormal sleep-wake cycles in patients with tuberculous meningitis: a case-control study. J. Neurol. Sci. 269, 126\u2013132. https:\/\/doi.org\/10.1016\/j.jns.2008.01.003 (2008).","journal-title":"J. Neurol. Sci."},{"key":"83176_CR19","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1128\/AAC.36.8.1648","volume":"36","author":"K Bartizal","year":"1992","unstructured":"Bartizal, K. et al. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin. Antimicrob. Agents Chemother. 36, 1648\u20131657 (1992).","journal-title":"Antimicrob. Agents Chemother."},{"key":"83176_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz193","author":"KA Marr","year":"2019","unstructured":"Marr, K. A. et al. A multicenter, longitudinal cohort study of cryptococcosis in HIV-negative people in the United States. Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am. https:\/\/doi.org\/10.1093\/cid\/ciz193 (2019).","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"83176_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.9740\/mhc.2016.07.207","volume":"6","author":"A Warstler","year":"2016","unstructured":"Warstler, A. & Bean, J. Antimicrobial-induced cognitive side effects. Ment. Health Clin. 6, 207\u2013214. https:\/\/doi.org\/10.9740\/mhc.2016.07.207 (2016).","journal-title":"Ment. Health Clin."},{"key":"83176_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4088\/pcc.v03n0104","volume":"3","author":"ES Brown","year":"2001","unstructured":"Brown, E. S. & Chandler, P. A. Mood and cognitive changes during systemic corticosteroid therapy. Prim. Care Companion J. Clin. Psychiatry 3, 17\u201321. https:\/\/doi.org\/10.4088\/pcc.v03n0104 (2001).","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"83176_CR23","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1176\/appi.ajp.2014.13091264","volume":"171","author":"LL Judd","year":"2014","unstructured":"Judd, L. L. et al. Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am. J. Psychiatry 171, 1045\u20131051. https:\/\/doi.org\/10.1176\/appi.ajp.2014.13091264 (2014).","journal-title":"Am. J. Psychiatry"},{"key":"83176_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000501617","volume":"110","author":"M Savas","year":"2020","unstructured":"Savas, M. et al. Systemic and local corticosteroid use is associated with reduced executive cognition, and mood and anxiety disorders. Neuroendocrinology 110, 282\u2013291. https:\/\/doi.org\/10.1159\/000501617 (2020).","journal-title":"Neuroendocrinology"},{"key":"83176_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/14779072.2020.1748011","volume":"18","author":"RS Fox","year":"2020","unstructured":"Fox, R. S., Peipert, J. D., Vera-Llonch, M., Phillips, G. & Cella, D. PROMIS(R) and Neuro-QoL(TM) measures are valid measures of health-related quality of life among patients with familial chylomicronemia syndrome. Expert Rev. Cardiovasc. Ther. 18, 231\u2013238. https:\/\/doi.org\/10.1080\/14779072.2020.1748011 (2020).","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"83176_CR26","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1007\/s11136-020-02596-1","volume":"29","author":"NE Carlozzi","year":"2020","unstructured":"Carlozzi, N. E. et al. Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD). Qual. Life Res. 29, 3419\u20133439. https:\/\/doi.org\/10.1007\/s11136-020-02596-1 (2020).","journal-title":"Qual. Life Res."},{"key":"83176_CR27","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.apmr.2010.06.020","volume":"91","author":"RK Bode","year":"2010","unstructured":"Bode, R. K. et al. Development and validation of participation and positive psychologic function measures for stroke survivors. Arch. Phys. Med. Rehabil. 91, 1347\u20131356. https:\/\/doi.org\/10.1016\/j.apmr.2010.06.020 (2010).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"83176_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.yebeh.2015.02.038","volume":"46","author":"JS Lai","year":"2015","unstructured":"Lai, J. S. et al. Validation of the Neuro-QoL measurement system in children with epilepsy. Epilepsy Behav. 46, 209\u2013214. https:\/\/doi.org\/10.1016\/j.yebeh.2015.02.038 (2015).","journal-title":"Epilepsy Behav."},{"key":"83176_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/mds.26546","volume":"31","author":"CJ Nowinski","year":"2016","unstructured":"Nowinski, C. J. et al. Neuro-QoL health-related quality of life measurement system: validation in Parkinson\u2019s disease. Mov. Disord. 31, 725\u2013733. https:\/\/doi.org\/10.1002\/mds.26546 (2016).","journal-title":"Mov. Disord."},{"key":"83176_CR30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1179\/2045772315Y.0000000016","volume":"38","author":"D Victorson","year":"2015","unstructured":"Victorson, D. et al. Measuring resilience after spinal cord injury: Development, validation and psychometric characteristics of the SCI-QOL Resilience item bank and short form. J. Spinal Cord Med. 38, 366\u2013376. https:\/\/doi.org\/10.1179\/2045772315Y.0000000016 (2015).","journal-title":"J. Spinal Cord Med."},{"key":"83176_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13023-018-0810-x","volume":"13","author":"A Slade","year":"2018","unstructured":"Slade, A. et al. Patient reported outcome measures in rare diseases: a narrative review. Orphanet. J. Rare Dis. 13, 61. https:\/\/doi.org\/10.1186\/s13023-018-0810-x (2018).","journal-title":"Orphanet. J. Rare Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83176-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83176-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83176-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:36:54Z","timestamp":1670038614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83176-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83176"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83176-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"29 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3673"}}